The analysis of treatment of aggressive fibromatosis using oral methotrexate chemotherapy.

Abstract

BACKGROUND:

Aggressive fibromatosis is a rare but invasive tumor infiltrating widely between fascia and muscle fibers. It has a high tendency to be locally recurrent despite complete resection. Effectiveness of adjuvant treatment for aggressive fibromatosis including radiotherapy, pharmacological agents, hormonal treatments, and chemotherapy have been previously reported. The purpose of this article was to collect and analyze all information regarding the effectiveness and side effects of oral methotrexate in aggressive fibromatosis.

METHODS:

From 2005 to 2011, eleven patients with aggressive fibromatosis treated with oral methotrexate at our institution were analyzed in this study. Oral methotrexate was administered once per week at 10 mg per week. Authors collected information about effectiveness concerning cases of local recurrence and metastasis.

RESULTS:

Eleven patients had remission, two patients had local recurrence. Fatal complications or toxicity were not observed.

CONCLUSIONS:

Oral methotrexate given at this dose and schedule was considered as a useful treatment in primary inoperable fibromatosis and recurrent fibromatosis.

• Authors: Gi Woon Yoon, Jae Do Kim, So Hak Chung
• Journal: Clinics in orthopedic surgery (Clin Orthop Surg) Vol. 6 Issue 4 Pg. 439-42 (Dec 2014) ISSN: 2005-4408 [Electronic] Korea (South)
• PMID: 25436069 (Publication Type: Journal Article)

Chemical References

• Antimetabolites, Antineoplastic
• Methotrexate

Topics

• Administration, Oral
• Adolescent
• Adult
• Aged
• Antimetabolites, Antineoplastic (administration & dosage)
• Child
• Female
• Fibromatosis, Aggressive (drug therapy, surgery)
• Humans
• Male
• Methotrexate (administration & dosage)
• Middle Aged
• Neoplasm Recurrence, Local (drug therapy, surgery)
• Retrospective Studies
• Young Adult